شخصية اليوم أحدث الأخبار

UAE: Oral insulin delivery system developed by Varsity

Princess Tarfa

The version developed by NYUAD is biocompatible when compared to two FDA-approved oral insulin delivery systems

For diabetic patients, a groundbreaking technology developed by NYU Abu Dhabi (NYUAD) that could eliminate the need for painful insulin injections.

The Trabolsi Research Group at NYUAD has created an oral insulin delivery device that could soon replace traditional intramuscular injections. The results, led by NYUAD research scientist Farah Benyettou and programme head of chemistry Ali Trabolsi, were reported in Chemical Science on Wednesday. This ground-breaking technology is the subject of a patent application in the United States.

“By using insulin-loaded nCOF nano-particles that exhibit insulin defence in the stomach as well as a glucose-responsive release, our work aims to overcome insulin oral delivery obstacles,” Benyettou said. “This technology responds quickly to an increase in blood sugar, but shuts off quickly to avoid insulin overdose, and will significantly improve the health of diabetic patients around the world,” she said.

An international team of researchers from Algeria, Spain, Saudi Arabia, and the United Kingdom collaborated on the creation of this procedure. In comparison to two FDA-approved oral insulin delivery systems, NYUAD's model is biocompatible and can provide the correct dose of insulin depending on blood sugar levels of the patient.

Visual Archive